Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-11 4:15 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Patel Shami Director | 0 | $0 | 1,435,252 (Indirect) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 50 | $1000 | 971,825 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 965,997 | $0 | 971,825 (Indirect) | View |
| 2024-09-30 Disposition | 2024-10-02 9:53 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 572,182 | $0 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 275 | $1000 | 5,795,408 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:53 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Interim Chairman and CEO | 5,312,983 | $0 | 5,795,408 (Direct) | View |
| 2024-09-30 Disposition | 2024-10-02 9:52 pm | N/A 2030-12-27 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 1,331,813 | $0 | 19,732,313 (Direct) | View |
| 2024-09-25 Exercise | 2024-10-02 9:52 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 1,002 | $1000 | 19,732,313 (Indirect) | View |
| 2024-09-25 Exercise | 2024-10-02 9:52 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Director | 19,358,578 | $0 | 19,732,313 (Indirect) | View |
| 2024-10-01 Option Award | 2024-10-02 7:03 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | KUCHARCHUK ANDREW ALBERT Chief Financial Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-02 7:02 pm | N/A 2034-09-30 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Pierce Kristen Chief Development Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-06-28 Option Award | 2024-07-01 4:01 pm | N/A 2034-06-28 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Carter Charles Ross Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:29 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rolfe Lindsey Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:28 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rapaport Robyn Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:28 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:27 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 572,182 | $0 | 572,182 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:27 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Corey Daniel Chief Technical Officer | 856,671 | $0 | 856,671 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:26 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Carter Charles Ross Chief Financial Officer | 395,387 | $0 | 395,387 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:24 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Byrnes Michael Director | 112,500 | $0 | 112,500 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 9:24 pm | N/A 2034-03-24 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 1,317,956 | $0 | 1,317,956 (Direct) | View |
| 2024-02-14 Option Award(A) | 2024-03-11 7:23 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 1,002 | $1000 | 512,329 (Indirect) | View |
| 2024-02-14 Option Award(A) | 2024-03-11 7:23 pm | N/A 2030-12-27 | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 13,857 | $0 | 512,329 (Indirect) | View |
| 2024-02-14 Other(A) | 2024-03-11 7:23 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 248,735 | $0 | 512,329 (Indirect) | View |
Ownership(A) | 2024-02-26 9:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Corey Daniel Chief Technical Officer | 0 | $0 | 686,470 (Direct) | View |
| 2024-02-14 Option Award(A) | 2024-02-21 5:57 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 50 | $1000 | 50 (Indirect) | View |
| 2024-02-14 Option Award(A) | 2024-02-21 5:55 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 1,002 | $1000 | 498,472 (Indirect) | View |
| 2024-02-14 Other(A) | 2024-02-21 5:55 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 248,735 | $0 | 498,472 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:41 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Loewy Caroline M Director | 5,828 | $0 | 11,656 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:40 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Kosacz Barbara Director | 5,828 | $0 | 11,656 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:39 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Geffken Daniel E. Chief Financial Officer | 10,002 | $0 | 20,004 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 7:39 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Fisher Douglas Carl President | 50 | $1000 | 91,650 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:39 pm | 2024-03-15 2029-02-14 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Fisher Douglas Carl President | 48,300 | $0 | 91,650 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 7:38 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 1,555 | $1000 | 6,297,801 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:38 pm | 2024-03-15 2029-02-14 | CERO THERAPEUTICS HOLDINGS INC. | CERO | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 5,646,244 | $0 | 6,297,801 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 7:38 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 0 | $0 | 6,297,801 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:38 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 1,555 | $1000 | 6,297,801 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 50 | $1000 | 11,706 (Direct) | View |
| 2024-02-14 Other | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | LAPORTE KATHLEEN Director | 5,828 | $0 | 11,706 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 100 | $1000 | 6,268,026 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 1,555 | $1000 | 6,268,026 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:37 pm | 2024-03-15 2029-02-14 | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 6,133,669 | $0 | 6,268,026 (Indirect) | View |
| 2024-02-14 Exercise | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 0 | $0 | 6,268,026 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:37 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Ehrlich Christopher B Director | 1,730 | $1000 | 6,268,026 (Indirect) | View |
| 2024-02-14 Option Award | 2024-02-16 7:36 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 1,002 | $1000 | 748,472 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:36 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | ATWOOD BRIAN G Chief Executive Officer | 373,735 | $0 | 748,472 (Direct) | View |
Ownership | 2024-02-16 7:29 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Rapaport Robyn Director | 0 | $0 | 50,000 (Direct) | View |
Ownership | 2024-02-16 7:28 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Corey Daniel Chief Technical Officer | 0 | $0 | 709,031 (Direct) | View |
Ownership | 2024-02-16 7:28 pm | 2024-02-14 N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Carter Charles Ross Chief Financial Officer | 0 | $0 | 5,000 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:41 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 36,733 | $10 | 5,682,977 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:41 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | PHOENIX BIOTECH SPONSOR LLC 10% Owner | 101,241 | $0 | 5,682,977 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:36 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner | 36,733 | $10 | 5,682,977 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:36 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Ehrlich Christopher B CEO and Secretary 10% Owner | 101,241 | $0 | 5,682,977 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:35 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Geffken Daniel E. Chief Financial Officer | 30,000 | $0 | 30,000 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:34 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Loewy Caroline M Director | 17,500 | $0 | 17,500 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:31 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Fisher Douglas President | 115,000 | $0 | 125,000 (Indirect) | View |
| 2021-10-08 Other | 2021-10-12 7:28 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | LAPORTE KATHLEEN Director | 17,500 | $0 | 17,500 (Indirect) | View |